Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III

Glycogen Storage Disease Type III Clinical Trial

Official title:
Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Patients 1 Year of Age and Over With GSD III

Status Terminated

Clinical Trial Summary

The primary objective of this study is to evaluate the incidence of hypoglycemia in adult and pediatric participants with glycogen storage disease type III (GSD III).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05196165
Study type	Observational
Source	Ultragenyx Pharmaceutical Inc
Contact
Status	Terminated
Phase
Start date	May 20, 2022
Completion date	March 2, 2023

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04990388` - Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)	Phase 1/Phase 2
Completed	`NCT04574830` - Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
Completed	`NCT02054832` - Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch	N/A
Active, not recruiting	`NCT02635269` - Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy	N/A
Completed	`NCT02448667` - Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies	N/A
Withdrawn	`NCT02385162` - Biomarker for Glycogen Storage Diseases (BioGlycogen)